US EditionPsychotropic Shortage: Situation Worsens for Quetiapine Due to "Production Delay"
3 Articles
3 Articles
Quetiapine, a drug commonly used for several psychiatric disorders, has been experiencing supply tensions for months. However, the situation has deteriorated further, while an American laboratory, whose production has so far limited these difficulties, is also affected by delays. The drug agency anticipates "a deterioration of availability" until "mid-September". - Psychotropic shortage: the situation worsens for quetiapine following a "retardan…
Treatments for several psychiatric disorders are experiencing a deterioration in availability, announced the drug agency on Tuesday, August 5th, until mid-September. She alerted in particular about the 300 mg and 400 mg doses of quetiapine used in the face of schizophrenia and bipolar disorders.
It will be even more difficult to find quetiapine, a drug commonly used for several psychiatric disorders, in the coming weeks, warned the drug agency on Tuesday. The National Drug Safety Agency (ANSM) announced, in a...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
